All sponsors

Shanghai Jiaolian Drug Research and Development Co., Ltd

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-20
ACTIVE TRIALS5
PHASE 3 / 2-34
RECRUITING5
READOUTS ≤12 MONTHS5
READOUT SLIPPED >6 MO20%

Delay Index: of 5 active trials registered more than a year ago, 1 have moved their primary completion (readout) date by more than 6 months since first registration (median +0.0 months). See all sponsors →

Open Shanghai Jiaolian Drug Research and Development Co., Ltd on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
B007
NCT06447597
P2/3RecruitingGeneralized Myasthenia Gravis1042026-12-30 (+6 mo)
B007
NCT06470191
P2/3RecruitingPrimary Membranous Nephropathy2162026-12-31
B013
NCT06434610
P2RecruitingPlatinum-resistant Recurrent Ovarian Cancer902026-12-31
B007
NCT06454357
P2/3RecruitingPemphigus1322026-12-31
B001
NCT06413654
P2/3RecruitingNeuromyelitis Optica Spectrum Disorders1322027-10-31